Design, synthesis and molecular docking studies of some morpholine linked thiazolidinone hybrid molecules
Open Access
- 30 September 2016
- journal article
- Published by European Journal of Chemistry in European Journal of Chemistry
- Vol. 7 (3), 271-279
- https://doi.org/10.5155/eurjchem.7.3.271-279.1427
Abstract
A novel series of morpoline linked thiazolidione hybrid molecules targeting bacterial enoyl acyl carrier protein (Enoyl-ACP) reductase were designed and synthesized through a three step reaction protocol, which involves simple reaction setup and moderate reaction conditions. The synthesized molecules were characterized with FT-IR, 1H NMR, 13C NMR and HRMS techniques. In vitro susceptibility tests against some Gram positive (Staphylococcus aureus and Bacillus subtilis) and Gram negative bacteria (Escherichia coli and Pseudomonas aeruginosa) gave highly promising results. Most of the molecules were found to be active against the tested bacterial strains. The most potent molecule (S2B7) gave MIC value of 2.0 µg/mL against Escherichia coli that was better than the reference drug streptomycin. Structure activity relationship showed nitro and chloro groups are crucial for bioactivity if present at meta position of arylidene ring in designed molecules. Molecular docking simulations against multiple targets showed that the designed molecules have strong binding affinity towards Enoyl-ACP reductase. Binding affinity of -8.6 kcal/mol was predicted for S2B7. Van der Waals forces, hydrogen bonding and hydrophobic interactions were predicted as the main forces of interaction.Keywords
This publication has 53 references indexed in Scilit:
- Discovery of Thiazolidine‐2,4‐Dione/Biphenylcarbonitrile Hybrid as Dual PPAR α/γ Modulator with Antidiabetic Effect: In vitro, In Silico and In Vivo ApproachesChemical Biology & Drug Design, 2013
- Synthesis, characterization and structure optimization of a series of thiazolidinone derivatives as Entamoeba histolytica inhibitorsEuropean Journal of Medicinal Chemistry, 2012
- Halogen bonding for rational drug design and new drug discoveryExpert Opinion on Drug Discovery, 2012
- Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacyBioorganic & Medicinal Chemistry Letters, 2011
- Privileged scaffolds for library design and drug discoveryCurrent Opinion in Chemical Biology, 2010
- How antibiotics kill bacteria: from targets to networksNature Reviews Microbiology, 2010
- A Medicinal Chemist’s Guide to Molecular InteractionsJournal of Medicinal Chemistry, 2010
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Residues Asp164 and Glu165 at the substrate entryway function potently in substrate orientation of alanine racemase fromE. coli: Enzymatic characterization with crystal structure analysisProtein Science, 2008
- Lack of development of new antimicrobial drugs: a potential serious threat to public healthThe Lancet Infectious Diseases, 2005